Skip to content

Nina Abukahok

Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.

3 papers in the library · 7 citations · publishing 2025-2026

Papers

Tusi use among the New York City nightclub-attending population.

Addiction (Abingdon, England) April 20, 2025 Joseph J Palamar, Nina Abukahok, Patricia Acosta et al. 7 citations

About 2.7% of adults attending electronic dance music nightclubs in New York City reported using Tusi (also called pink cocaine or tusibí) in the past year. Tusi is a drug mixture often containing ketamine and other substances, and users may be unaware of its composition. Hispanic individuals had five times higher odds of use compared with white individuals. People who used ecstasy/MDMA, ketamine, or 2C series drugs in the past year were more likely to also use Tusi. Those reporting Tusi use were more likely to test positive for cocaine, ketamine, MDMA, methamphetamine, or synthetic cathinones via saliva testing, and some tested positive for cocaine, ketamine, or methamphetamine even without reporting past-year use of those drugs.

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental & clinical pharmacology July 1, 2026 Nina Abukahok, Steven Lawrence, Samrachana Adhikari et al.

In the New York metropolitan area, over a third of clinics advertising ketamine for psychiatric conditions offer it for at-home use, raising safety concerns. A 2025 systematic web search identified 233 clinics; 36.5% prescribed ketamine for at-home use, 51.5% listed a medical doctor, 42.9% advertised oral ketamine, and depression was the most common condition treated (94.0%). Clinics advertising oral ketamine were over four times more likely to offer at-home use, while those listing a medical doctor were about half as likely. The findings suggest a consumer-oriented advertising approach that may warrant monitoring and clearer guidance to mitigate safety risks.

An Update on the Epidemiology of Tusi ("Pink Cocaine").

Current addiction reports January 1, 2025 Nina Abukahok, Nicole D Fitzgerald, Joseph J Palamar

Tusi, or 'pink cocaine,' is a drug mixture containing ketamine and MDMA, often with additional substances like synthetic cathinones, cocaine, or methamphetamine. Its inconsistent chemical makeup complicates surveillance and harm reduction. Drug checking services have identified ketamine and MDMA as main components, with ketamine concentrations increasing over time in Spain. Surveys in Spain and Colombia show rising initiation, polysubstance use, and misclassification of tusi's contents. Harms stem largely from the polysubstance mixtures rather than any single component, yet mortality data typically focus on individual drugs. Tusi represents a novel trend: a blend of substances defined by its color and nightlife association, requiring standardized surveys, expanded drug checking, and improved toxicological monitoring.